Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

This Month in Archives of Dermatology

This Month in Archives of Dermatology Prevention of Glucocorticoid-Induced Osteoporosis in Immunobullous Diseases With Alendronate The mainstay of therapy of immunobullous disease continues to be long-term glucocorticoid use, despite the risks of bone loss and fracture. Bisphosphonate use has been advocated in treatment guidelines for patients being treated with glucocorticoids for longer than 3 months. However, published trials have involved white patients with rheumatologic and respiratory diseases for which the doses are generally lower than for immunobullous diseases. In this randomized, double-blind, placebo-controlled trial, Tee et al demonstrate a significant increase in bone mineral density with alendronate therapy in patients treated with oral corticosteroids for immunobullous disease, suggesting that using bisphosphonates is imperative in this patient population. See Article Impact of Smoking in Cutaneous Lupus Erythematosus Between 59% and 85% of patients with systemic lupus erythematosus (LE) develop dermatologic involvement. The specific manifestations of cutaneous LE are diverse and can be grouped into acute, subacute, and chronic subtypes. In this prospective longitudinal cohort study, Piette et al demonstrate that current smokers with lupus have worse disease and lower quality of life and respond less well to treatment when they need both antimalarial agents and immunomodulators. These data further strengthen the need for smoking cessation in the cutaneous LE population. See Article Association of Pharyngitis With Oral Antibiotic Use for the Treatment of Acne Many inconsistent concerns have been voiced about the safety of long-term antibiotic use. Because of the high prevalence of acne and frequent use of antibiotics to control acne, patients with acne are the ideal group in which to study the effects of long-term antibiotic use. In this cross-sectional prospective cohort study, Margolis et al demonstrate that the odds of developing self-reported pharyngitis was more than 3 times that at baseline in patients receiving oral antibiotics for acne vs those who were not receiving oral antibiotics. The cause of this phenomenon is not known, but this finding was not associated with group A streptococcus. See Article Population-Based Estimates of the Occurrence of Multiple vs First Primary Basal Cell Carcinomas in 4 European Regions Basal cell carcinoma (BCC) is the most common cancer among whites by far, and incidence rates are increasing worldwide. Multiple primary tumors in patients with a BCC history and the large total number of patients with BCC translate into substantial costs and an important public health burden. However, the precise magnitude of BCC incidence and prevalence remains unknown because the total number of BCC cases continues to be markedly underreported by cancer registries that often report information only for first primary BCC. In this cancer registry evaluation, de Vries et al demonstrate that the total annual incidence rates are about 1.3 times higher than the rates of first primary BCC. See Article Soluble Adenylyl Cyclase Antibody Profile as a Diagnostic Adjunct in the Assessment of Pigmented Lesions Melanocytic proliferations remain among the most critical diagnostic challenges in the field of dermatopathology. A few immunohistochemical stains, such as HMB45 and Ki67, are routinely used to distinguish benign lesions from melanoma. Neither is specific or especially sensitive. In this qualitative study, Magro et al demonstrate that a novel monoclonal antibody against soluble adenylyl cyclase (sAC) produced distinctive patterns that paralleled melanoma genesis. The sAC expression pattern is complex but seems discriminatory, and it seems to provide a confirmatory test to distinguish benign from malignant lesions. See Article http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

This Month in Archives of Dermatology

Archives of Dermatology , Volume 148 (3) – Mar 1, 2012
Download PDF
1 page
Read Article

This Month in Archives of Dermatology

Abstract

Prevention of Glucocorticoid-Induced Osteoporosis in Immunobullous Diseases With Alendronate The mainstay of therapy of immunobullous disease continues to be long-term glucocorticoid use, despite the risks of bone loss and fracture. Bisphosphonate use has been advocated in treatment guidelines for patients being treated with glucocorticoids for longer than 3 months. However, published trials have involved white patients with rheumatologic and respiratory diseases for which the doses are...
Loading next page...
 
/lp/american-medical-association/this-month-in-archives-of-dermatology-dRHM9gZ0Rc
Publisher
American Medical Association
Copyright
Copyright © 2012 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archdermatol.2011.519
Publisher site
See Article on Publisher Site

Abstract

Prevention of Glucocorticoid-Induced Osteoporosis in Immunobullous Diseases With Alendronate The mainstay of therapy of immunobullous disease continues to be long-term glucocorticoid use, despite the risks of bone loss and fracture. Bisphosphonate use has been advocated in treatment guidelines for patients being treated with glucocorticoids for longer than 3 months. However, published trials have involved white patients with rheumatologic and respiratory diseases for which the doses are generally lower than for immunobullous diseases. In this randomized, double-blind, placebo-controlled trial, Tee et al demonstrate a significant increase in bone mineral density with alendronate therapy in patients treated with oral corticosteroids for immunobullous disease, suggesting that using bisphosphonates is imperative in this patient population. See Article Impact of Smoking in Cutaneous Lupus Erythematosus Between 59% and 85% of patients with systemic lupus erythematosus (LE) develop dermatologic involvement. The specific manifestations of cutaneous LE are diverse and can be grouped into acute, subacute, and chronic subtypes. In this prospective longitudinal cohort study, Piette et al demonstrate that current smokers with lupus have worse disease and lower quality of life and respond less well to treatment when they need both antimalarial agents and immunomodulators. These data further strengthen the need for smoking cessation in the cutaneous LE population. See Article Association of Pharyngitis With Oral Antibiotic Use for the Treatment of Acne Many inconsistent concerns have been voiced about the safety of long-term antibiotic use. Because of the high prevalence of acne and frequent use of antibiotics to control acne, patients with acne are the ideal group in which to study the effects of long-term antibiotic use. In this cross-sectional prospective cohort study, Margolis et al demonstrate that the odds of developing self-reported pharyngitis was more than 3 times that at baseline in patients receiving oral antibiotics for acne vs those who were not receiving oral antibiotics. The cause of this phenomenon is not known, but this finding was not associated with group A streptococcus. See Article Population-Based Estimates of the Occurrence of Multiple vs First Primary Basal Cell Carcinomas in 4 European Regions Basal cell carcinoma (BCC) is the most common cancer among whites by far, and incidence rates are increasing worldwide. Multiple primary tumors in patients with a BCC history and the large total number of patients with BCC translate into substantial costs and an important public health burden. However, the precise magnitude of BCC incidence and prevalence remains unknown because the total number of BCC cases continues to be markedly underreported by cancer registries that often report information only for first primary BCC. In this cancer registry evaluation, de Vries et al demonstrate that the total annual incidence rates are about 1.3 times higher than the rates of first primary BCC. See Article Soluble Adenylyl Cyclase Antibody Profile as a Diagnostic Adjunct in the Assessment of Pigmented Lesions Melanocytic proliferations remain among the most critical diagnostic challenges in the field of dermatopathology. A few immunohistochemical stains, such as HMB45 and Ki67, are routinely used to distinguish benign lesions from melanoma. Neither is specific or especially sensitive. In this qualitative study, Magro et al demonstrate that a novel monoclonal antibody against soluble adenylyl cyclase (sAC) produced distinctive patterns that paralleled melanoma genesis. The sAC expression pattern is complex but seems discriminatory, and it seems to provide a confirmatory test to distinguish benign from malignant lesions. See Article

Journal

Archives of Dermatology – American Medical Association

Published: Mar 1, 2012

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

Sign up
for free
Start 14 day
Free Trial